Czechia· CZ-0191565
BLEOMEDAC
A bleomycin product containing bleomycin sulfate, registered in Czechia by Medac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel. The same ATC class is registered in 15 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Bleomycin is registered in 15 of 19 countries.
Countries holding a registration under ATC L01DC01 (bleomycin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Bleomycin · ATC L01DC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- BLEOMYCIN SULFATE
- Manufacturer
- Medac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- Country
- Czechia (CZ)
- ATC code
- L01DC01
- ATC class
- Bleomycin
- Defined daily dose
- 3 mg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl01915651X10MLCZK 1336.16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
212 interactions on record for bleomycin.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bleomycin · interactions on record
212 records
- 33 severe
- 105 moderate
- 15 minor
- 59 info
Most severe, free to view
- CladribineL01BB04severe
- Brentuximab vedotinL01FX05severe
- Brentuximab vedotinL01XC12severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bleomycin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBleomycine Hikma 15000 IUHikma Farmacêutica
- PolandBleomedacmedac Gesellschaft fuer klinische Spezialpraeparate mbH
- United StatesBleomycinFresenius Kabi USA, LLC
- GermanyBleomedacMedac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
- FinlandBleomycin AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Bleomycine Hikma
- Germany · Bleomedac
- Estonia · Bleomycin Medac
- Finland · Bleomycin Baxter
- France · Bleomycine Bellon
- Italy · Bleoprim
- Lithuania · Bleomycin Medac
- Luxembourg · Bleomycine Hikma
- Latvia · Bleomycin Medac
- Poland · Bleomedac
- Portugal · Bleocin
- Slovakia · Bleomedac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/87b809d1-bb6e-424f-b5de-1060297df049 GET /v1/drugs/87b809d1-bb6e-424f-b5de-1060297df049?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ PLV SOL",
"source": "sukl",
"strength": "15000IU",
"pack_size": "1X10ML",
"substance": "BLEOMYCIN SULFATE",
"cz_kod_sukl": "0191565",
"product_type": "CH",
"substance_codes": "3309",
"registration_state": "R",
"registration_number": "44/298/11-C"
}See everything about bleomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.